
Eight Roads Ventures
Description
Eight Roads Ventures is a prominent global venture capital firm, distinguished by its extensive reach and substantial financial backing from Fidelity International. The firm manages over $11 billion in assets, operating from key offices in the UK, China, India, Japan, and the US. This global footprint enables Eight Roads to offer portfolio companies not only capital but also strategic insights and access to a vast international network, leveraging deep local market expertise across diverse geographies.
The firm's investment strategy is primarily focused on high-growth companies within the technology and healthcare sectors. In Europe and the US, their typical investment sweet spot spans from Series A to Series C rounds, targeting innovative solutions in areas such as enterprise SaaS, fintech, and digital health. In Asian markets, their investment scope broadens to encompass consumer and financial services, adapting to regional market dynamics and opportunities. Eight Roads emphasizes building long-term partnerships, providing operational support and leveraging its global ecosystem to help portfolio companies scale.
Eight Roads Ventures typically commits initial investments ranging from $5 million to over $50 million, showcasing its flexibility to support companies across various growth stages. The firm boasts a robust track record of backing successful ventures, with notable investments in companies like Alibaba, Icertis, and Toast, underscoring its ability to identify and nurture future market leaders. Recent capital raises, including a $450 million European fund and a $250 million India fund, both closed in 2022, further solidify their commitment to these strategic regions and their capacity for significant capital deployment.
Investor Profile
Eight Roads Ventures has backed more than 535 startups, with 10 new investments in the last 12 months alone. The firm has led 233 rounds, about 44% of its total and boasts 112 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, China, India.
- Strong thematic focus on Health Care, Software, Biotechnology.
- Led 2 rounds in the past year.
- Typical check size: $5M – $50M.
Stage Focus
- Series B (26%)
- Series Unknown (24%)
- Series A (22%)
- Series C (15%)
- Series D (5%)
- Seed (5%)
- Series E (1%)
- Private Equity (1%)
Country Focus
- United States (35%)
- China (23%)
- India (13%)
- United Kingdom (8%)
- Japan (8%)
- France (2%)
- Singapore (2%)
- Switzerland (1%)
- Spain (1%)
- Israel (1%)
Industry Focus
- Health Care
- Software
- Biotechnology
- Information Technology
- Medical
- Saas
- Financial Services
- Analytics
- Fintech
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.